Xontogeny’s Garabedian Must-Watch Interview: Getting Discovered, Fundraising, Outlook & More

This can’t-miss interview features one of the titans of the early-stage life sci VC world. Chris Garabedian, founder of the Xontogeny fund, fueled by Perceptive Advisors, shares his thoughts on you how to get your company funded, effective entrepreneurship, and what the current US and international political climate could mean for the future of biotech startups. Xontogeny is a regular at RESI conferences and will be one of the flagship investors at RESI Boston June. Focusing on seed, series A and series B, they can invest $0.5M to $20M and facilitate larger check sizes for later stages with their Perceptive Advisors umbrella. Xontogeny is open to working with all types of management teams, including first-time entrepreneurs.

This video spans multiple topics, from the benefits of engaging an experienced, active investor in the seed round, to how to Xontogeny and what Chris would like to see in the initial outreach, as well as how they may be involved in various stages of development. The video concludes by discussing the industry as it now stands, and where Chris thinks it will go, in light of the changes in recent months in the US and international political and economic climate. Chris gave a lot of very valuable advice to early-stage life science companies on how to focus on what will make their fundraise the most successful.